Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia

Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support ...

AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)

AccuStem Sciences, Inc. (OTCQB: ACUT ), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced the execution of a pilot study ...
TruthoutOpinion

The Trump Administration Has Already Accomplished Vast Portions of Project 2025

Project 2025 is rooted in injecting narrower interpretations of gender, sexuality and race in federal policy. It calls for ...
APC

Gender in Digital Coalition statement on Revision 2 of the WSIS+20 Outcome Document

The Gender in Digital Coalition presents its comments on Revision 2 of the WSIS+20 Outcome Document. Throughout the entire review process, our coalition has consistently highlighted a set of ...